滑鼠模型市場：按模型類型、服務、技術、應用、最終用戶和地區分類

據估計，2026年小鼠模型市值為20.5億美元，預計到2033年將達到40.2億美元。預計從2026年到2033年，其複合年成長率將達到10.1%。

全球小鼠模型市場是生物醫學研究生態系統中的關鍵組成部分，是科學發現和藥物研發的重要工具。實驗室小鼠，尤其是基因轉殖小鼠，由於其與人類的遺傳相似性、生物系統易於理解以及研究方案的完善，已成為臨床前研究的黃金標準。該市場涵蓋多種小鼠模型，旨在模擬特定的人類疾病和狀況，例如近交系小鼠、非近交系小鼠、基因轉殖小鼠（GEMs）和免疫力缺乏小鼠。

隨著慢性病、癌症、神經系統疾病和代謝性疾病的日益普遍，對能夠精確模擬人類病理生理過程的精密動物模型的需求也日益成長。學術機構、製藥公司、生技公司和受託研究機構都高度依賴這些模型進行藥物發現、毒性測試、療效測試和個人化醫療研究。基因工程技術（例如 CRISPR-Cas9）的進步進一步推動了市場成長。這些技術能夠開發出更精準、更具疾病特異性的鼠模型，進而提高研究成果，並加速實驗室研究成果向臨床應用的轉化。

市場動態

全球小鼠模型市場的成長受到多種因素的驅動，這些因素共同推動了製藥和生物技術領域的強勁擴張。其中一個關鍵因素是藥物發現和開發活動的快速發展，製藥公司越來越依賴先進的小鼠模型來評估治療效果和安全性，然後再進行人體臨床試驗。癌症、糖尿病、心血管疾病和神經系統疾病等慢性疾病的日益普遍，使得開發能夠精確模擬人類病理生理過程的疾病特異性小鼠模型成為必要，從而推動了市場需求。

此外，基因工程技術的進步，特別是CRISPR-Cas9和其他基因編輯技術的出現，徹底改變了基因轉殖小鼠模型的建構方式，使研究人員能夠開發出更精準、更具針對性的實驗系統。然而，市場面臨著許多限制因素，阻礙了其成長。嚴格的動物實驗監管框架，包括倫理考量和合規要求，既阻礙了市場擴張，也增加了研究機構的營運成本。人們對體外模型、晶片器官技術和電腦建模等替代測試方法的日益關注，對傳統的動物實驗研究模式構成了潛在威脅。此外，培育、維護和飼養特定品系小鼠的高成本，以及對專用設施和訓練有素的人員的需求，也為小規模研究機構進入該領域設置了障礙。

儘管面臨這些挑戰，個人化醫療方法的日益普及也帶來了巨大的機會。個人化醫療需要使用患者特異性的小鼠模型來開發針對個別患者的治療方法。提供專業小鼠模型服務的受託研究機構（CRO）的擴張為市場成長帶來了可觀的機遇，尤其是在研究基礎設施快速發展的新興市場。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球小鼠模型市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球小鼠模型市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 透過各種用於分析全球小鼠模型市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球小鼠模型市場：依模型類型分類，2021-2033年

• 基因轉殖小鼠（GEMs）
• 近交系小鼠
• 非近交系小鼠
• 雜交/共基因小鼠
• 自然突變小鼠

第5章 全球小鼠模型市場：依服務類型分類，2021-2033年

• 繁殖服務
• 冷凍保存、復甦和重新定序服務
• 基因檢測和特徵分析服務
• 利用模型進行體外和體外測試服務
• 客製化模型開發服務

第6章 全球小鼠模型市場：依技術分類，2021-2033年

• CRISPR/Cas9
• 胚胎幹細胞（ESC）技術
• 核轉移技術
• 顯微注射技術
• 其他（例如，TALEN、ZFN）

第7章 全球小鼠模型市場：依應用領域分類，2021-2033年

• 腫瘤學研究
• 免疫學和發炎研究
• 糖尿病研究
• 心血管研究
• 神經系統疾病研究
• 罕見疾病研究
• 毒理學和安全性評估
• 其他（例如，代謝性疾病、感染疾病）

第8章 全球滑鼠模型市場：依最終使用者分類，2021-2033年

• 製藥和生物技術公司
• 學術和研究機構
• 受託研究機構（CRO）
• 政府和非營利組織

第9章 全球小鼠模型市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Charles River Laboratories
• The Jackson Laboratory
• Inotiv
• genOway
• Taconic Biosciences
• Janvier Labs
• Crown Bioscience
• Cyagen Biosciences
• GemPharmatech
• Shanghai Model Organisms Center（SMOC）
• Biocytogen
• Ozgene Pty Ltd
• Trans Genic Inc.
• Harbour BioMed
• JSR Life Sciences

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Mice Model Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 4.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

The global mice model market represents a critical segment within the broader biomedical research ecosystem, serving as an indispensable tool for scientific discovery and pharmaceutical development. Laboratory mice, particularly genetically modified strains, have become the gold standard for preclinical research due to their genetic similarity to humans, well-characterized biological systems, and established research protocols. This market encompasses various mouse models including inbred strains, outbred stocks, Genetically Engineered Models (GEMs), and immunodeficient mice, each designed to replicate specific human diseases and conditions.

The increasing prevalence of chronic diseases, cancer, neurological disorders, and metabolic conditions has intensified the demand for sophisticated animal models that can accurately mimic human pathophysiology. Academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations heavily rely on these models for drug discovery, toxicology studies, efficacy testing, and personalized medicine research. The market's growth is further propelled by technological advancements in genetic engineering techniques such as CRISPR-Cas9, which enable the development of more precise and disease-specific mouse models, thereby enhancing research outcomes and accelerating the translation of laboratory findings into clinical applications.

Market Dynamics

The global mice model market growth is driven by several compelling factors that collectively fuel its robust expansion across the pharmaceutical and biotechnology sectors. The primary driver stems from the exponential growth in drug discovery and development activities, where pharmaceutical companies increasingly rely on sophisticated mouse models to evaluate therapeutic efficacy and safety profiles before advancing to human trials. The rising prevalence of chronic diseases, including cancer, diabetes, cardiovascular disorders, and neurological conditions, necessitates the development of disease-specific mouse models that can accurately replicate human pathophysiology, thereby driving market demand.

Additionally, technological advancements in genetic engineering, particularly CRISPR-Cas9 and other gene-editing technologies, have revolutionized the creation of genetically modified mouse models, enabling researchers to develop more precise and targeted experimental systems. However, the market faces significant restraints that challenge its growth trajectory. Stringent regulatory frameworks governing animal research, including ethical considerations and compliance requirements, create barriers for market expansion and increase operational costs for research institutions. The growing emphasis on alternative testing methods, such as in-vitro models, organ-on-chip technologies, and computational modeling, poses a potential threat to traditional animal-based research paradigms. Furthermore, the high costs associated with breeding, maintaining, and housing specialized mouse strains, coupled with the need for specialized facilities and trained personnel, limit accessibility for smaller research organizations.

Despite these challenges, substantial opportunities emerge from the increasing adoption of personalized medicine approaches, which require patient-specific mouse models for tailored therapeutic development. The expansion of contract research organizations offering specialized mouse model services presents lucrative opportunities for market growth, particularly in emerging markets where research infrastructure is rapidly developing.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mice model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Taconic Biosciences, Janvier Labs, Crown Bioscience, Cyagen Biosciences, GemPharmatech, Shanghai Model Organisms Center (SMOC), Biocytogen, Ozgene Pty Ltd, Trans Genic Inc., Harbour BioMed, and JSR Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global mice model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mice model market

Market Segmentation

• Model Type Insights (Revenue, USD Bn, 2021 - 2033)
• Genetically Engineered Mice (GEM)
  • Knockout Mice
  • Knock-in Mice
  • Conditional Mutant Mice
• Inbred Mice
• Outbred Mice
• Hybrid/Congenic Mice
• Spontaneous Mutant Mice
• Service Insights (Revenue, USD Bn, 2021 - 2033)
• Breeding Services
• Cryopreservation, Rederivation, and Resequencing Services
• Genetic Testing and Characterization Services
• Model In-vivo and In-vitro Testing Services
• Custom Model Development Services
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
• CRISPR/Cas9
• Embryonic Stem Cell (ESC) Technology
• Nuclear Transfer Technology
• Microinjection Technology
• Others (e.g., TALENs, ZFNs)
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Oncology Research
• Immunology and Inflammation Studies
• Diabetes Research
• Cardiovascular Research
• Neurological Disease Research
• Rare Disease Research
• Toxicology and Safety Assessment
• Others (e.g., Metabolic Disorders, Infectious Diseases)
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)
• Government and Nonprofit Organizations
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Charles River Laboratories
• The Jackson Laboratory
• Inotiv
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Crown Bioscience
• Cyagen
• GemPharmatech
• Shanghai Model Organisms Center, Inc.
• Biocytogen
• Ozgene Pty Ltd
• Trans Genic Inc.
• Harbour BioMed
• JSR Life Sciences, LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Mice Model Market, By Model Type
  • Global Mice Model Market, By Service
  • Global Mice Model Market, By Technology
  • Global Mice Model Market, By Application
  • Global Mice Model Market, By End User
  • Global Mice Model Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Mice Model Market, By Model Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Genetically Engineered Mice (GEM)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Knockout Mice
    • Knock-in Mice
    • Conditional Mutant Mice
• Inbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Outbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hybrid/Congenic Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Spontaneous Mutant Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Mice Model Market, By Service, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Breeding Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cryopreservation, Rederivation, and Resequencing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genetic Testing and Characterization Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Model In-vivo and In-vitro Testing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Custom Model Development Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Mice Model Market, By Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• CRISPR/Cas9
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Embryonic Stem Cell (ESC) Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Nuclear Transfer Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Microinjection Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., TALENs, ZFNs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Mice Model Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Immunology and Inflammation Studies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diabetes Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cardiovascular Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Neurological Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Rare Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Toxicology and Safety Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., Metabolic Disorders, Infectious Diseases)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Mice Model Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Government and Nonprofit Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Mice Model Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Jackson Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Inotiv
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• genOway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Taconic Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Janvier Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Crown Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyagen Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GemPharmatech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Shanghai Model Organisms Center (SMOC)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biocytogen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ozgene Pty Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Trans Genic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Harbour BioMed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• JSR Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us